Why ProPhase Labs (PRPH) Stock Is Down 47% Today
Why ProPhase Labs (PRPH) Stock Is Down 47% Today
ProPhase Labs Inc (NASDAQ:PRPH) shares are trading lower by 47% to 75 cents during Friday's session. The company announced an underwritten public offering of 4.17 million shares of common stock at 72 cents per share, totaling approximately $3 million before expenses and discounts.
prophase labs公司（納斯達克：PRPH）股價在星期五交易中下跌了47%，至75美分。該公司宣佈以每股72美分的價格，通過承銷發行方式發行了417萬股普通股，總金額約爲300萬美元，未計費用和折扣。
The company also granted underwriters a 45-day option to purchase up to an additional 625,500 shares to cover over-allotments. The offering, set to close on November 12, is managed by ThinkEquity.
該公司還授予承銷商45天的期權，購買額外的625,500股股票用於覆蓋超額配售。這次發行計劃於11月12日結束，由ThinkEquity管理。
ProPhase Labs says proceeds will fund working capital and general corporate purposes, including capital investments, product development, commercialization and potential acquisitions in diagnostics, genomics and consumer products.
prophase labs表示，籌集的資金將用於營運資金和一般企業用途，包括資本投資、產品開發、商業化以及在診斷、基因組學和消費品領域的潛在收購。
Read Also: Bitcoin ETFs Saw Record $1.38 Billion Inflows On Thursday
閱讀更多：比特幣etf在星期四創下創紀錄的13.8億美元淨流入
According to data from Benzinga Pro, PRPH has a 52-week high of $7.48 and a 52-week low of $0.66.
據Benzinga Pro的數據顯示，PRPH的52周最高價爲7.48美元，52周最低價爲0.66美元。
譯文內容由第三人軟體翻譯。
